Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004062 |
ID: | TCMBANKHE004062 |
植物拉丁名: |
|
功能与主治: | To open orifices and arouse spirit, quicken blood and dissipate binds, disperse swelling and relieve pain./Angina pectoris, cerebral thrombosis, vascular migraine, carcinoma, febrile diseases clouded spirit, wind stroke with phlegm reversal, qi depression and fulminant reversal, malignity stroke stupor, amenorrhea due to blood stasis, concretion conglomeration accumulation and gathering, sudden pain in heart and abdomen, knocks and falls, wound, impediment pain numbness, malign sore with welling abscess and flat abscess, throat impediment, mouth sore, gan of teeth and gum, otitis media. |
药用植物名: | 麝香 |
药用部位: | dried secretion obtained from musk gland of musk deer |
药味: | Warm; Pungent |
经络: | Spleen; Heart |
治疗类型: | 开窍 |
TCM_ID_id: | 4428 |
TCMSP_id: | 633 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000549 | muscol | C4H13N3 | 191.27 g/mol | CCN(CC)C(=O)C1=CC=CC(=C1)C | |
| TCMBANKIN002357 | 3'(s)-hydroxy-4'(r)-angeloyloxy-3',4'-dihydro-xanthyletin | 3'(s)-hydroxy-4'(r)angeloyloxy-3',4'-dihydroxanthyletin | C19H20O6 | ||
| TCMBANKIN002667 | allantoin | [2,5-dioxo-imidazolidin-(4e)-ylidene]-urea; (2,5-dioxoimidazol-4-yl)urea; AKOS016004588; AJ-81964; 2AL; AX8170921; BG00903559; DTXSID00425870; KB-212680; X4187; 1-(2,5-DIOXO-2,5-DIHYDRO-1H-IMIDAZOL-4-YL)UREA; CTK8C1374; AC1OA9WW; SCHEMBL9203157; TC-155121; AK-55526; 2,5-DIOXO-1H-IMIDAZOL-4-YLUREA; ZINC24779397; 105245-87-2; ANW-66376 | C4H6N4O3 | 158.12 | C1(C(=O)NC(=O)N1)NC(=O)N |
| TCMBANKIN005536 | 3beta-hydroxy-5alpha-androstan-17-one | 3β-hydroxy-5α-androstan-17-one | C19H30O2 | 290.4 g/mol | CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O |
| TCMBANKIN006486 | 5 beta-androstan-3 alpha,17 alpha-diol | 5β-androstan-3α,17α-diol | C19H32O2 | ||
| TCMBANKIN007017 | cyclovirobuxine | C26H46N2O | 402.7 g/mol | CC(C1C(CC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)NC)C)C)O)NC | |
| TCMBANKIN007373 | 3alpha-hydroxy-6-oxo-5alpha-cholanic acid | 3α-hydroxy-6-oxo-5α-cholanicacid | C24H38O4 | CC(CCC(=O)O)C1CCC2C1(CCC3C2C(=O)CC4C3(CCC(C4)O)C)C | |
| TCMBANKIN007519 | muscone | 3-methylcyclopentadecanone-1 | C16H30O | 238.41 g/mol | CC1CCCCCCCCCCCCC(=O)C1 |
| TCMBANKIN007881 | 5-deacetyltaxachitriene b | C28H40O11 | 552.6 g/mol | CC1=C2C(C(=C(C(CC(C(=CC(C(C2(C)C)CC1OC(=O)C)O)CO)O)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN008323 | musennin | C51H82O21 | 1031.2 g/mol | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)OC6C(C(C(CO6)O)O)OC7C(C(C(CO7)O)O)OC8C(C(C(CO8)O)OC9C(C(C(C(O9)CO)O)O)O)O)C)C(=O)O)C | |
| TCMBANKIN008495 | 3α一Acetyl一11一oxo 一12一en一24 一carboxylic acid | ||||
| TCMBANKIN009388 | 3-methylcyclotridecan-1-one | Cyclotridecanone,3-methyl-; 61415-11-0; 3-Methylcyclotridecanone; EINECS 262-772-7; AKOS030592914; CTK5B3200; 3-Methylcyclotridecan-1-one; SCHEMBL14118250; AK633836; AC1MI4F5 | C14H26O | 210.36 g/mol | CC1CCCCCCCCCCC(=O)C1 |
| TCMBANKIN010186 | androst-4,6-diene-3,17-dione | C19H24O2 | CC12CCC3C(C1CCC2=O)C=CC4=CC(=O)CCC34C | ||
| TCMBANKIN011962 | cholest-4-ene-3-one | C27H44O | CC(CCC(C(C)(C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O)OC(=O)C)COC5C(C(C(CO5)OC(=O)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN012629 | 3β,19,20s,21-tetrahydroxydammar-24-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyra-nosyl(1→3)]-α-l-arabinopyranosyl}-21-o-β-d-glucopyranoside | C52H88O21 | |||
| TCMBANKIN015658 | 5-cis-cyclotetradecen-1-one | C14H24O | C1CCCCC(=O)CCCC=CCCC1 | ||
| TCMBANKIN018197 | hydroxymuscopyridine b | C16H25NO | 247.38 | CC1CCCCCCCCC2=NC(=CC=C2)C1O | |
| TCMBANKIN018917 | s-methyl cysteine | s-methylcysteine | C4H9NO2S | 135.18 | CSCC(C(=O)O)N |
| TCMBANKIN020961 | morin | SMR000058259; C.I. Natural Yellow 8; NCGC00015672-12; KBioGR_002268; 480-16-0; SPBio_000929; 8NFQ3F76WR; 5-18-05-00492 (Beilstein Handbook Reference); NCGC00022214-05; ZINC03881558; BDBM26658; DivK1c_000958; Zlut prirodni 11; NCGC00178000-02; morin ; NCGC00022214-03; 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one #; NCI60_001647; NCGC00015672-04; ST50308676; Morin; X1189; MCULE-2387347344; 3,7,2',4'-Pentahydroxyflavone; Zlut prirodni 11 [Czech]; NCGC00015672-09; 2',3,4',5,7-Pentahydroxy-Flavone; AX8140380; C10105; HMS3262K14; NCGC00015672-02; Bio-0589; CTK5B4214; ZX-AT022489; Bois d'arc; NCGC00015672-05; 2',4',5,7-Tetrahydroxyflavonol; 4CH-024478; BRD-K11590034-001-01-0; LMPK12112517; Tox21_500776; NCGC00015672-10; SC-44859; Lopac-M-4008; 2',4',5, 7-Tetrahydroxyflavan-3-ol; A-9317; BC684344; KBio2_004282; BG01594705; Al-Morin; regid855692; C.I. 75660; KBio2_006850; Spectrum_001234; D0NJ4H; C.I. Natural Yellow 11 (VAN); HMS502P20; 3,5 7 2 4-Pentahydroxyflavone; LS-69029; C.I. Natural Yellow 11; Aurantica; EINECS 207-542-9; ZINC3881558; C.I.Natural Yellow 8; 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 9CI; KBio1_000958; Bois d,Arc; C15H10O7; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; CHEMBL28626; FT-0628989; Morin hydrate; 2',3,4',5,7-pentahydroxy flavone; NSC19801; Aluminum Ionophore I; Spectrum5_000737; DTXSID1022398; 2',4',5,7-Pentahydroxyflavone; UNII-8NFQ3F76WR; 69870_FLUKA; MLS006012034; AC1NQYUY; 3,5,7,2',4'-Pentahydroxyflavone; LP00776; 4H-1-Benzopyran-4-one, 2-2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-; Spectrum4_001924; Toxylon Pomiferum; NCGC00015672-13; Osage Orange; Bois d'arc [French]; AI3-38057; BSPBio_003541; NCGC00015672-08; NCGC00022214-07; ST24039108; BRN 0327474; SR-01000000157-7; Osage Orange Crystals; MLS000069618; GTPL411; KB-220543; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; SBB008853; IDI1_000958; CHEBI:75092; KBio2_001714; KBio3_002824; 2',3,5,7-Pentahydroxyflavone; I14-19447; Osage Orange Extract; 3,5,7,2',4'-Pentahydroxyflavonol; 2',4',3,5,7-Pentahydroxyflavone; MolPort-001-742-584; 2'-Hydroxypelargidenolon 1522; SPECTRUM1502259; AN-23488; NSC-19801; Lopac0_000776; SR-01000000157-2; M-8200; AK111274; Spectrum3_001941; NCGC00178000-01; Aluminum Ionophore I, Selectophore(TM), function tested; AIDS001407; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; KBioSS_001714; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one; cid_5281670; SMP1_000199; M 4008; NCGC00015672-06; Spectrum2_000715; SR-01000000157-6; MFCD00006826; AJ-46640; NCGC00022214-06; NSC 19801; I14-114104; SCHEMBL19984; 2',3,4',5,7-Pentahydroxyflavone; CCRIS 8680; ACon1_000260; 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-; NCGC00015672-07; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one; MEGxp0_001864; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-chromenone; 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-,monohydrate; NCGC00022214-04; EU-0100776; NCGC00261461-01; P0041; Flavone,3,4',5,7-pentahydroxy-; 91A9D69E-FAB0-45CD-90E5-DEEFBADE86C1; HMS1921P12; AIDS-001407; NCGC00015672-11; BIDD:ER0115; 2',4',5,7-Tetrahydroxyflavan-3-ol; Bois d'Arc; 11128-85-1; AKOS001582671; NINDS_000958; NCGC00015672-03; Flavone, 2',3,4',5,7-pentahydroxy-; Calico Yellow; 2',5,7-Tetrahydroxyflavan-3-ol; 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; SDCCGMLS-0003296.P003; CCG-39036; NCGC00015672-14; NCGC00015672-01; SR-01000000157; Morin, p.a., 97.0%; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone; MORIN, REAG; YXOLAZRVSSWPPT-UHFFFAOYSA-N | C15H10O7 | 302.24 | C1=CC(=C(C=C1O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN021765 | decamine | C30H40ClN4+ | 492.1 g/mol | CC1=[N+](C2=CC=CC=C2C(=C1)N)CCCCCCCCCC[N+]3=C(C=C(C4=CC=CC=C43)N)C.[Cl-] | |
| TCMBANKIN022686 | Cholesteryl ferulate | AC1NSTJT; cholesteryl ferulate; [(3S,10R,13R,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate | C37H54O4 | 562.8 g/mol | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C=CC5=CC(=C(C=C5)O)OC)C)C |
| TCMBANKIN022775 | musclide a1 | AC1NSYW8; (6-hydroxy-2-methylheptan-3-yl) hydrogen sulfate | CC(C)C(CCC(C)O)OS(=O)(=O)O | ||
| TCMBANKIN023650 | 1β,2β,5α,11-tetraacetoxy-8α-benzoyl-4α-hydrox-y-7β-nicotinoyl-dihydroagarofuran | 1beta,2beta,5alpha,11-tetraacetoxy-8alpha-benzoyl-4alpha-hydroxy-7beta-nicotinoyl-dihydroagarofuran | |||
| TCMBANKIN023929 | hydroxymuscopyridine a | C16H25NO | 247.38 g/mol | CC1CCCCCCCC(C2=CC=CC(=N2)C1)O | |
| TCMBANKIN026259 | testosterone | SR-05000001542-1; Spectrum4_000114; AB00053134_04; KBioSS_001813; Spectrum2_001799; HMS2091C05; IDI1_000744; KBioGR_000468; Spectrum_001333; MLS002554341; SR-05000001542; AC1NWAJL; KBio2_006949; SBI-0052631.P003; NCGC00178631-01; NSC-755838; SCHEMBL2600415; NINDS_000744; CHEMBL67934; SPECTRUM307023; (10R,13S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; KBio2_004381; SMR001475622; HMS502F06; CCG-39734; KBio1_000744; Spectrum3_000787; NSC755838; BSPBio_002494; Spectrum5_001759; BRD-A55393291-001-02-4; DivK1c_000744; SPBio_001757; KBio2_001813; Pharmakon1600-00307023; HMS3088I14; KBio3_001714 | C19H28O2 | 288.4 g/mol | CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C |
| TCMBANKIN027813 | 3α-hydroxyilicicacid | C15H24O4 | |||
| TCMBANKIN029346 | cyclotetradecan-1-one | C14H26O | 210.36 g/mol | C1CCCCCCC(=O)CCCCCC1 | |
| TCMBANKIN030283 | androst-4-ene-3,17-dione | C19H26O2 | 286.4 g/mol | CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4=O)C | |
| TCMBANKIN034024 | 3,,5-dihydroxybenzoicacid-o-xylopyranosyl-glucopyranoside | 532.6 | |||
| TCMBANKIN035513 | muscopyridine | C16H25N | 231.38 | CC1CCCCCCCCC2=NC(=CC=C2)C1 | |
| TCMBANKIN036944 | 5 beta-Bufol sufate | C27H48O5 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@]([H])(O[H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(C([H])([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])(O[H])C([H])([H])O[H])C ([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])[C@@]3([H])[C@]([H])(O[H])C4([H])[H])[C@@]4([H])C([H])([H])[C@]1([H])O[H] | ||
| TCMBANKIN037333 | 5 alpha-Benzoyl-4 alpha-hydroxy-1 beta,8 alpha-dinicotinoyl-dihydro-agarofuran | 5 alpha-benzoyl-4 alpha-hydroxy-1 beta,8 alpha-dinicotinoyl-dihydro-agarofuran | C34H36N2O8 | 600.72 | C1([H])([H])[C@]([H])(OC(c2c([H])c([H])c([H])nc2[H])=O)[C@](C([H])([H])[H])([C@@]([H])(OC(c3c([H])nc([H])c([H])c3[H])=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])O[H])[C@]4(OC5(C([H])([H])[H])C([H])( [H])[H])[C@]([H])(OC(=O)c6c([H])c([H])c([H])c([H])c6[H])[C@@]15[H] |
| TCMBANKIN042463 | 3beta-hydroxy-androst-5-ene-17-one | 3β-hydroxy-androst-5-ene-17-one | C19H28O2 | 288.4 g/mol | CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C |
| TCMBANKIN044237 | 22-Cyclopentyloxil-22-deisopentyl-3beta-hydroxyl-guranstanol | C27H42O3 | [C@]1([H])(O[H])C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]4([H])[C@]([H])(O[C@@]([H])(OC5([H])C([H])([H])C([H] )([H])C([H])([H])C5([H])[H])[C@@]4([H])C([H])([H])[H])C6([H])[H])[C@@]36[H])C1([H])[H] | ||
| TCMBANKIN044801 | 3α-Ureido-androst-4-en-17-one | ||||
| TCMBANKIN048083 | 3alpha-Hydroxy-5beta-androstan-17-one | 3α-hydroxy-5β-androstan-17-one | C19H30O2 | 274.441 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=O)C([H])([H])C2([H])[H])[C@]23[H])[C@@]3([H])C([H])([H])C4([H])[H])[C@@]4([H])C([H])([H])[C@]1([H]) O[H] |
| TCMBANKIN058616 | normuscone | cyclopentadecanone | C15H28O | 224.38 g/mol | C1CCCCCCCC(=O)CCCCCC1 |
| TCMBANKIN059249 | CLR | 5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N | C27H46O | 386.65 | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN060111 | 17alpha-estradiol | C18H24O2 | 272.4 g/mol | CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O | |
| TCMBANKIN060942 | nonane | C9H20 | 128.26 | CCCCCCCCC | |
| TCMBANKIN061681 | Nornuciferine;n-nornuciferine;daechualkoloid A;(s)-nornuciferine | NORAPORPHINE, 1,2-DIMETHOXY-; dl-Nornuciferine; 1,2-Dimethoxynoraporphine; 4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-, (+-)- (9CI); nornuciferine; 54750-04-8 | C18H19NO2 | 281.35 | COC1=C(C2=C3C(CC4=CC=CC=C42)NCCC3=C1)OC |
| TCMBANKIN061849 | 1-methoxy-4-(2-propenyl)-benzene | 4-Allylanisole;estragole;esdragol;Terragon;methylchavicol;CCRIS 1317; MolPort-000-156-967; MFCD00008653; Estragol (methylchavicol); DSSTox_CID_575; Anisole, p-allyl-; Esdragol; 1-allyl-4-methoxy-benzene; DTXSID0020575; 4-allylanisol; Methyl chavicole (estragole); p-Methoxyallylbenzene; Benzene, 1-methoxy-4-(2-propen-1-yl)-; NCGC00091434-01; chavicyl methylether; CTK7A3557; Methyl chavicole; UNII-9NIW07V3ET; Estragol; SR-01000838348; 4-06-00-03817 (Beilstein Handbook Reference); Ether, p-allylphenyl methyl; NSC 404113; Tarragon; 140-67-0; DSSTox_RID_75667; O080; Chavicol methyl ether; Benzene, 1-methoxy, 4-prop-2-enyl; AK109291; FEMA No. 2411; p-Allylphenyl methyl ether; p-allylanisole, 4-allyl-1-methoxybenzene, methyl chavicol; Chavicol, O-methyl-; NSC-404113; CHEMBL470671; CCG-214642; 4-Allylanisole, analytical standard; FEMA 2411; 1-METHOXY-4-(2-PROPENYL)BENZENE; FEMA Number 2411; EPA Pesticide Chemical Code 062150; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; HMS2268E24; SMR000112379; p-Allylanisole; SPECTRUM1505117; 1-methoxy-4-(prop-2-en-1-yl)benzene; Chavicyl methyl ether; chavicol methylether; C10452; NCI-C60946; Allylphenyl methyl ether, p-; estragon;p-allylanisole; EINECS 205-427-8; AI3-16052; Esteragol; ZINC967635; 4-Allylanisole, purum, >=97.0% (GC); CHEBI:4867; 1407-27-8; Estragole (natural); NCGC00259936-01; MLS001065575; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; AC1Q4FE9; 1-Methoxy-4-(2-propen-1-yl)-Benzene; Methylchavicol; Chavicol, methyl-; p-Allyl-Anisole; ACMC-1BW75; KB-36193; 3-(p-Methoxyphenyl)propene; 1-methoxy-4-(2-propenyl)-benzene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; AKOS000121300; p-Allylmethoxybenzene; Methyl-Chavicol; AC1L1RR7; Tox21_302930; 3-(4-Methoxyphenyl)-1-propene; ST50824126; BRN 1099454; Isoanthethole; LS-821; Esdragon; ZFMSMUAANRJZFM-UHFFFAOYSA-N; I01-10181; Estragole, analytical standard; 9NIW07V3ET; O-Methyl-Chavicol; Terragon; 4-Allyl-1-methoxybenzene; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; HSDB 5412; 4-Allylanisole, 98%; Chavicyl methyl ether; AN-17349; 1-Methoxy-4-(2-propenyl)benzene, 9CI; A0702; 4-Allylanisole; para-allylanisole; AC1Q4CFH; SCHEMBL57204; WLN: 1U2R DO1; SR-01000838348-2; FT-0617414; J-007415; NCGC00091434-02; TC-109325; CAS-140-67-0; isoanethole, 4-Allylanisole; ANW-20580; 4-Methoxyallylbenzene; Tox21_202387; Estragole; NSC404113; Esdragole; 77525-18-9; AJ-24538; DSSTox_GSID_20575; NCGC00091434-03; Para-allylanisole (estragole); ZB015470; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1-Allyl-4-methoxybenzene; NCGC00256481-01; 4-Allylanisole, >=98%, FCC; 1-Methoxy-4-(2-propen-1-yl)benzene; Isoanethole;34098_RIEDEL; 3-(p-Methoxyphenyl)propene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; 1-METHOXY-4-(2-PROPENYL)BENZENE; Anisole, p-allyl-; EPA Pesticide Chemical Code 062150; 1-allyl-4-methoxy-benzene; Esdragol; FEMA Number 2411; p-Allylmethoxybenzene; NCGC00091434-02; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; p-Methoxyallylbenzene; 4-Methoxyallylbenzene; BRN 1099454; WLN: 1U2R DO1; SPECTRUM1505117; p-Allylanisole; LS-821; Esdragon; NCGC00091434-01; Estragol; Chavicyl methyl ether; C10452; Estragole; 4-06-00-03817 (Beilstein Handbook Reference); NSC404113; Esdragole; NCI-C60946; NSC 404113; 77525-18-9; 4-Allyl-1-methoxybenzene; Tarragon; 140-67-0; Allylphenyl methyl ether, p-; HSDB 5412; EINECS 205-427-8; ZINC00967635; AI3-16052; Isoanethole; 1-methoxy-4-prop-2-enyl-benzene; A29208_ALDRICH; 05820_FLUKA; Chavicol methyl ether; 05818_FLUKA; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1407-27-8; W241105_ALDRICH; Estragole (natural); 1-Allyl-4-methoxybenzene; FEMA No. 2411; 4-Allylanisole; 1-Methoxy-4-(2-propen-1-yl)benzene; Chavicol, O-methyl-; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; Methylchavicol | C10H12O | 148.2 g/mol | COC1=CC=C(C=C1)CC=C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab